# BAMLANIVIMAB
(CoV555)   |   mAb vs. SARS-CoV-2 Spike Glycoprotein

*REGION: RBD (Receptor Binding Domain)*

---
## Interaction Residues
- E484
- Q493
- S494
- L452
- F490


`SOURCE: https://www.nature.com/articles/s41598-021-99827-3`
